Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dky468
PubMed Identifier: 30544247
Publication URI: http://europepmc.org/abstract/MED/30544247
Type: Journal Article/Review
Volume: 74
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 3
ISSN: 0305-7453